According to new research by the Hepatitis C Trust, patients with the virus in the UK are being failed

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.584, 2009-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Balancing perspective: the response to feelings of being condemned with the hepatitis C virus

By Faye Bethany Irurita Vera

Journal of Substance Use, Vol. 8, Iss. 2, 2003-06 ,pp. : 92-103

Radcliffe Press

Access to resources Recommend Favorite

Interferon plus lamivudine may be effective in patients with dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

New hepatitis C virus drug discovery strategies and model systems

By Hussain Snawar Barretto Naina Uprichard Susan L

Expert Opinion on Drug Discovery, Vol. 7, Iss. 9, 2012-09 ,pp. : 849-859

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis C virus: new advances trap an age-old killer

By Desselberger Ulrich

Future Virology, Vol. 1, Iss. 6, 2006-11 ,pp. : 703-708

Future Medicine

Access to resources Recommend Favorite

A New Potent NS5A Inhibitor in the Management of Hepatitis C Virus: Ravidasvir

Current Drug Discovery Technologies, Vol. 15, Iss. 1, 2018-04 ,pp. : 24-31

Bentham Science Publishers

Access to resources Recommend Favorite